Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from MedPlus Health Services Ltd. ( (IN:MEDPLUS) ).
MedPlus Health Services’ subsidiary Optival Health Solutions has received two separate orders from state Drugs Control Administration authorities suspending the drug licences of individual stores in Karwar, Karnataka and Uppal Prashanti Nagar, Telangana for two days each, citing violations under Rule 65 of the Drugs and Cosmetics Act, 1940 and associated Rules. The company estimates a combined potential revenue loss of approximately Rs 2.79 lakh from these short-term suspensions, which affect only the specified outlets and are not expected to materially disrupt overall operations, but underscore ongoing regulatory scrutiny of compliance standards in the organized retail pharmacy sector.
More about MedPlus Health Services Ltd.
MedPlus Health Services Limited operates in the retail pharmacy and healthcare services sector in India, primarily through its chain of medical stores and its subsidiary Optival Health Solutions Private Limited. The company focuses on selling prescription drugs, over-the-counter medicines and related health products to consumers across multiple states, leveraging a wide network of outlets in key markets such as Telangana and Karnataka.
Average Trading Volume: 21,491
Technical Sentiment Signal: Strong Buy
Current Market Cap: 99.73B INR
Find detailed analytics on MEDPLUS stock on TipRanks’ Stock Analysis page.